AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 2862882 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 30000
Study 31818716 — intervention group
Group type: EXPERIMENTAL
Intervention: OLA-guided therapy
Number of subjects: 991
Study 31818716 — intervention group
Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 991
Study 31818716 — intervention group
Group type: EXPERIMENTAL
Intervention: NNRTI-based ART with efavirenz
Number of subjects: 991
Study 31364397 — intervention group
Group type: EXPERIMENTAL
Intervention: FLARE‐RT (functional lung avoidance radiation therapy)
Number of subjects: 28
Study 31364397 — intervention group
Group type: COMPARATOR
Intervention: LUNG‐RT (conventionally planned radiation therapy)
Number of subjects: 28
Study 31364397 — intervention group
Group type: EXPERIMENTAL
Intervention: FLARE‐RT
Number of subjects: 28
Study 31364397 — intervention group
Group type: COMPARATOR
Intervention: LUNG‐RT
Number of subjects: 28
Study 27862904 — intervention group
Group type: EXPERIMENTAL
Intervention: Systolic blood pressure (SBP) <120 mm Hg
Number of subjects: 984
Study 27862904 — intervention group
Group type: EXPERIMENTAL
Intervention: Hispanics on the US mainland
Number of subjects: 984
Study 27862904 — intervention group
Group type: EXPERIMENTAL
Intervention: Hispanics
Number of subjects: 984
Study 27862904 — intervention group
Group type: EXPERIMENTAL
Intervention: Mainland Hispanics
Number of subjects: 984
Study 27862904 — intervention group
Group type: COMPARATOR
Intervention: Hispanics vs non-Hispanics
Number of subjects: 984
Study 25617858 — intervention group
Group type: EXPERIMENTAL
Intervention: Palmolein
Number of subjects: 28
Study 25617858 — intervention group
Group type: EXPERIMENTAL
Intervention: Olive oil
Number of subjects: 28
Study 23782470 — intervention group
Group type: EXPERIMENTAL
Intervention: InPAct program (interactive patient booklet and standardized training of physicians)
Number of subjects: 1200
Study 23782470 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 1200
Study 22074711 — intervention group
Group type: EXPERIMENTAL
Intervention: Viral load arm (clinical monitoring, quarterly CD4 counts, and viral load measurements)
Number of subjects: 1094
Study 22074711 — intervention group
Group type: EXPERIMENTAL
Intervention: CD4 arm (clinical monitoring and CD4 counts)
Number of subjects: 1094
Study 22074711 — intervention group
Group type: COMPARATOR
Intervention: Clinical arm (clinical monitoring alone)
Number of subjects: 1094
Study 22074711 — intervention group
Group type: EXPERIMENTAL
Intervention: CD4 arm
Number of subjects: 1094
Study 19449251 — intervention group
Group type: EXPERIMENTAL
Intervention: Focal knee joint cooling (20 min with two 1.5-litre ice bags)
Number of subjects: 11
Study 19449251 — intervention group
Group type: COMPARATOR
Intervention: Control (quiet sitting)
Number of subjects: 11
Study 16850671 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose monophasic oral contraceptive pills
Number of subjects: 70
Study 16850671 — intervention group
Group type: COMPARATOR
Intervention: Expectant management
Number of subjects: 70
Study 14676238 — intervention group
Group type: COMPARATOR
Intervention: Control group (healthy participants)
Number of subjects: 94
Study 14676238 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypertensive patients
Number of subjects: 94
Study 14676238 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetic patients
Number of subjects: 94
Study 14676238 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetic-hypertensive patients
Number of subjects: 94
Study 14676238 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient group (hypertensive, diabetic, or both)
Number of subjects: 94
Study 14676238 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall analysis including study group variable
Number of subjects: 94
Study 11506150 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual Vacuum Aspiration (MVA)
Number of subjects: 42
Study 11506150 — intervention group
Group type: EXPERIMENTAL
Intervention: Electric Vacuum Aspiration (EVA)
Number of subjects: 42
Study 9261292 — intervention group
Group type: EXPERIMENTAL
Intervention: Controlled short-duration hyperventilation (HV) for 1 minute
Number of subjects: 0
Study 9261292 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 8396158 — intervention group
Group type: EXPERIMENTAL
Intervention: Lisinopril (20 mg)
Number of subjects: 0
Study 8396158 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 2876775 — intervention group
Group type: EXPERIMENTAL
Intervention: Tulobuterol (2 mg BID)
Number of subjects: 40
Study 2876775 — intervention group
Group type: COMPARATOR
Intervention: Salbutamol (2 mg TID)
Number of subjects: 40
Study 2876775 — intervention group
Group type: EXPERIMENTAL
Intervention: Tulobuterol
Number of subjects: 40
Study 2876775 — intervention group
Group type: COMPARATOR
Intervention: Salbutamol
Number of subjects: 40
Study 2876775 — intervention group
Group type: EXPERIMENTAL
Intervention: Tulobuterol and Salbutamol
Number of subjects: 40
Study 31992538 — intervention group
Group type: EXPERIMENTAL
Intervention: Residual incompetent tributaries without truncal incompetence
Number of subjects: 280
Study 31992538 — intervention group
Group type: EXPERIMENTAL
Intervention: No venous incompetence
Number of subjects: 280
Study 31992538 — intervention group
Group type: COMPARATOR
Intervention: Incompetent tributaries only
Number of subjects: 280
Study 31992538 — intervention group
Group type: COMPARATOR
Intervention: Combined incompetence of truncal vein and tributaries
Number of subjects: 280
Study 31992538 — intervention group
Group type: COMPARATOR
Intervention: Presence of perforating vein incompetence
Number of subjects: 280
Study 29980331 — intervention group
Group type: EXPERIMENTAL
Intervention: 36 months of ADT
Number of subjects: 630
Study 29980331 — intervention group
Group type: COMPARATOR
Intervention: 18 months of ADT
Number of subjects: 630
Study 26810391 — intervention group
Group type: EXPERIMENTAL
Intervention: Power toothbrush
Number of subjects: 109
Study 26810391 — intervention group
Group type: COMPARATOR
Intervention: Manual toothbrush
Number of subjects: 109
Study 23782864 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-led biofeedback-assisted relaxation (night group)
Number of subjects: 128
Study 23782864 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-led biofeedback-assisted relaxation (morning-night group)
Number of subjects: 128
Study 23782864 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-led biofeedback-assisted relaxation (morning group)
Number of subjects: 128
Study 23782864 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 128
Study 21715200 — intervention group
Group type: EXPERIMENTAL
Intervention: Coping Strategies Questionnaire after 3 months
Number of subjects: 740
Study 21715200 — intervention group
Group type: EXPERIMENTAL
Intervention: Distraction coping strategy
Number of subjects: 740
Study 21715200 — intervention group
Group type: EXPERIMENTAL
Intervention: Reinterpreting coping strategy
Number of subjects: 740
Study 21715200 — intervention group
Group type: EXPERIMENTAL
Intervention: Catastrophizing coping strategy
Number of subjects: 740
Study 21715200 — intervention group
Group type: EXPERIMENTAL
Intervention: Praying and hoping coping strategy
Number of subjects: 740
Study 19393999 — intervention group
Group type: EXPERIMENTAL
Intervention: HA-bound spermatozoa
Number of subjects: 241
Study 19393999 — intervention group
Group type: COMPARATOR
Intervention: HA-ICSI
Number of subjects: 241
Study 16917681 — intervention group
Group type: EXPERIMENTAL
Intervention: Additional support programme
Number of subjects: 101
Study 16917681 — intervention group
Group type: COMPARATOR
Intervention: Informative programme
Number of subjects: 101
Study 16917681 — intervention group
Group type: COMPARATOR
Intervention: Control group (treatment as usual)
Number of subjects: 101
Study 16200752 — intervention group
Group type: EXPERIMENTAL
Intervention: Heuristic fuzzy logic approach to EMG pattern recognition for multifunctional prosthesis control
Number of subjects: 5
Study 11988654 — intervention group
Group type: EXPERIMENTAL
Intervention: Diaspirin cross-linked hemoglobin (DCLHb)
Number of subjects: 0
Study 11988654 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 0
Study 10396195 — intervention group
Group type: EXPERIMENTAL
Intervention: Nedocromil 2%
Number of subjects: 24
Study 10396195 — intervention group
Group type: COMPARATOR
Intervention: Fluorometholone 0.1%
Number of subjects: 24
Study 8583779 — intervention group
Group type: EXPERIMENTAL
Intervention: Epoprostenol infusion (initial rate of 2 ng/kg/min, increased to max 8 ng/kg/min)
Number of subjects: 12
Study 8583779 — intervention group
Group type: COMPARATOR
Intervention: Placebo infusion
Number of subjects: 12
Study 2248854 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 ml kg‐1 h‐1 intravenous crystalloid fluid
Number of subjects: 12
Study 2248854 — intervention group
Group type: COMPARATOR
Intervention: 5-10 ml kg‐1 h‐1 intravenous crystalloid fluid
Number of subjects: 12
Study 2248854 — intervention group
Group type: EXPERIMENTAL
Intervention: Low sodium (glucose) solutions
Number of subjects: 12
Study 6988946 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxycycline 200 mg orally 12‐18 hours preoperatively and 200 mg intravenously during the subsequent 4 days
Number of subjects: 84
Study 6988946 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxycycline 200 mg orally 12‐18 hours preoperatively and 200 mg intravenously during the subsequent 4 days + 2 grams of tinidazole orally as a single dose 12‐18 hours preoperatively
Number of subjects: 84
Study 6988946 — intervention group
Group type: COMPARATOR
Intervention: Bacitracin/neomycin tablets during the 3 days immediately prior to operation
Number of subjects: 84
Study 31667855 — intervention group
Group type: EXPERIMENTAL
Intervention: Superparamagnetic iron oxide (SPIO) nanoparticles detected by a handheld magnetic probe
Number of subjects: 220
Study 31667855 — intervention group
Group type: COMPARATOR
Intervention: Radioisotope (RI) method using radioactive colloids (99m Tc) and blue dye (indigo carmine)
Number of subjects: 220
Study 29340750 — intervention group
Group type: EXPERIMENTAL
Intervention: ARTISS fibrin sealant (Human)
Number of subjects: 9
Study 29340750 — intervention group
Group type: COMPARATOR
Intervention: Control (no ARTISS)
Number of subjects: 9
Study 26296929 — intervention group
Group type: EXPERIMENTAL
Intervention: OTO‐201 4 mg
Number of subjects: 83
Study 26296929 — intervention group
Group type: EXPERIMENTAL
Intervention: OTO‐201 12 mg
Number of subjects: 83
Study 26296929 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 83
Study 26296929 — intervention group
Group type: COMPARATOR
Intervention: Sham
Number of subjects: 83
Study 24482348 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative prednisone 30 mg daily × 7 days
Number of subjects: 36
Study 24482348 — intervention group
Group type: COMPARATOR
Intervention: Postoperative placebo pill daily × 7 days
Number of subjects: 36
Study 23188903 — intervention group
Group type: EXPERIMENTAL
Intervention: Peri-articular injection of local anaesthetic
Number of subjects: 0
Study 23188903 — intervention group
Group type: COMPARATOR
Intervention: Femoral nerve block
Number of subjects: 0
Study 20083871 — intervention group
Group type: EXPERIMENTAL
Intervention: Gabapentin 600 mg
Number of subjects: 50
Study 20083871 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 17186396 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised exercise in addition to routine anticoagulation and class II compression stockings
Number of subjects: 72
Study 17186396 — intervention group
Group type: COMPARATOR
Intervention: Routine anticoagulation and class II compression stockings without exercise
Number of subjects: 72
Study 17186396 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (exercise and control)
Number of subjects: 72
Study 15168035 — intervention group
Group type: EXPERIMENTAL
Intervention: Whey peptide hydrolysate (WHY)
Number of subjects: 6
Study 15168035 — intervention group
Group type: EXPERIMENTAL
Intervention: Casein hydrolysate (CAHY)
Number of subjects: 6
Study 15168035 — intervention group
Group type: EXPERIMENTAL
Intervention: Casein whole protein (C)
Number of subjects: 6
Study 15168035 — intervention group
Group type: EXPERIMENTAL
Intervention: Whey whole protein (W)
Number of subjects: 6
Study 15168035 — intervention group
Group type: EXPERIMENTAL
Intervention: Peptide hydrolysates (WHY and CAHY)
Number of subjects: 6
Study 15168035 — intervention group
Group type: EXPERIMENTAL
Intervention: All solutions (WHY, CAHY, C, W)
Number of subjects: 6
Study 12704877 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-FU plus FA plus LEV (arm B, 283 pts.)
Number of subjects: 813
Study 12704877 — intervention group
Group type: COMPARATOR
Intervention: 5-FU plus LEV (arm A, 279 pts.)
Number of subjects: 813
Study 12704877 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-FU plus LEV with IFNa (arm C, 251 pts.)
Number of subjects: 813
Study 10022937 — intervention group
Group type: EXPERIMENTAL
Intervention: Proteases (Wobenzym drg)
Number of subjects: 20
Study 10022937 — intervention group
Group type: COMPARATOR
Intervention: Systemic antiedema and hemostyptic therapy (Dicynone drg and Reparil drg)
Number of subjects: 20
Study 7484628 — intervention group
Group type: EXPERIMENTAL
Intervention: Compression ratios from 1:1 to more than 40:1 applied to MR images
Number of subjects: 3
Study 7484628 — intervention group
Group type: EXPERIMENTAL
Intervention: Compression at 20:1
Number of subjects: 3
Study 7484628 — intervention group
Group type: EXPERIMENTAL
Intervention: Compression ratios tested (including 40:1)
Number of subjects: 3
Study 2189367 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose beclomethasone dipropionate (750 micrograms three times daily for five days)
Number of subjects: 24
Study 2189367 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 389223 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol 100 mg once daily
Number of subjects: 9
Study 389223 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol 50 mg twice daily
Number of subjects: 9
Study 389223 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol 200 mg once daily
Number of subjects: 9
Study 389223 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study 389223 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol (any dosage)
Number of subjects: 9
Study 389223 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol once daily
Number of subjects: 9
Study 30944686 — intervention group
Group type: COMPARATOR
Intervention: 0.2 mg hydromorphone coadministered with ropivacaine (group H1)
Number of subjects: 80
Study 30944686 — intervention group
Group type: COMPARATOR
Intervention: 0.4 mg hydromorphone coadministered with ropivacaine (group H2)
Number of subjects: 80
Study 30944686 — intervention group
Group type: COMPARATOR
Intervention: 0.6 mg hydromorphone coadministered with ropivacaine (group H3)
Number of subjects: 80
Study 30944686 — intervention group
Group type: EXPERIMENTAL
Intervention: 0 mg hydromorphone coadministered with ropivacaine (group H0)
Number of subjects: 80
Study 28288592 — intervention group
Group type: EXPERIMENTAL
Intervention: manualized Short Term Psychodynamic Psychotherapy (mSTPP)
Number of subjects: 109
Study 28288592 — intervention group
Group type: COMPARATOR
Intervention: treatment as usual without specific training (tauSTPP)
Number of subjects: 109
Study 25939591 — intervention group
Group type: EXPERIMENTAL
Intervention: 1,000 mg resveratrol daily for 4 months
Number of subjects: 66
Study 25939591 — intervention group
Group type: COMPARATOR
Intervention: Control group (placebo)
Number of subjects: 66
Study 23297849 — intervention group
Group type: EXPERIMENTAL
Intervention: Removable dentures supported with four implants
Number of subjects: 56
Study 23297849 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed reconstruction using eight implants
Number of subjects: 56
Study 23297849 — intervention group
Group type: COMPARATOR
Intervention: Various implant retained and/or supported prostheses
Number of subjects: 56
Study 20571097 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-GDP solution
Number of subjects: 33
Study 20571097 — intervention group
Group type: COMPARATOR
Intervention: Standard PD fluid
Number of subjects: 33
Study 19410143 — intervention group
Group type: EXPERIMENTAL
Intervention: 2D planning for small breast size
Number of subjects: 20
Study 19410143 — intervention group
Group type: EXPERIMENTAL
Intervention: 2D planning for medium breast size
Number of subjects: 20
Study 19410143 — intervention group
Group type: EXPERIMENTAL
Intervention: 2D planning for large breast size
Number of subjects: 20
Study 19410143 — intervention group
Group type: EXPERIMENTAL
Intervention: CT-based planning and 3D planning for medium and large breast sizes
Number of subjects: 20
Study 17449110 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of amantadine 100 mg t.i.d. and baclofen 30 mg t.i.d.
Number of subjects: 8
Study 17449110 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 17449110 — intervention group
Group type: EXPERIMENTAL
Intervention: Cocaine (20 mg and 40 mg doses)
Number of subjects: 8
Study 14680448 — intervention group
Group type: EXPERIMENTAL
Intervention: Carvedilol (mean daily dose 41.8 mg)
Number of subjects: 0
Study 14680448 — intervention group
Group type: COMPARATOR
Intervention: Metoprolol tartrate (mean daily dose 85 mg)
Number of subjects: 0
Study 15264940 — intervention group
Group type: EXPERIMENTAL
Intervention: Provider alert
Number of subjects: 409
Study 15264940 — intervention group
Group type: EXPERIMENTAL
Intervention: Provider and scheduler alert
Number of subjects: 409
Study 15264940 — intervention group
Group type: COMPARATOR
Intervention: Control (no reminder)
Number of subjects: 409
Study 10080304 — intervention group
Group type: EXPERIMENTAL
Intervention: Titanium group (n = 22)
Number of subjects: 47
Study 10080304 — intervention group
Group type: COMPARATOR
Intervention: High-gold alloy group (n = 25)
Number of subjects: 47
Study 10080304 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 47
Study 8749837 — intervention group
Group type: EXPERIMENTAL
Intervention: Lofepramine (noradrenaline-specific reuptake inhibitor)
Number of subjects: 183
Study 8749837 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine (serotonin-specific reuptake inhibitor)
Number of subjects: 183
Study 1903230 — intervention group
Group type: EXPERIMENTAL
Intervention: Classical splenorenal shunt
Number of subjects: 94
Study 1903230 — intervention group
Group type: EXPERIMENTAL
Intervention: Distal splenorenal shunt
Number of subjects: 94
Study 1903230 — intervention group
Group type: EXPERIMENTAL
Intervention: Esophagogastric devascularization with splenectomy
Number of subjects: 94
Study 1903230 — intervention group
Group type: COMPARATOR
Intervention: All three surgical procedures
Number of subjects: 94
Study 7039519 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapid refeeding
Number of subjects: 0
Study 7039519 — intervention group
Group type: COMPARATOR
Intervention: Standard graduated feeding regimen
Number of subjects: 0
Study 31112788 — intervention group
Group type: EXPERIMENTAL
Intervention: Galantamine
Number of subjects: 24
Study 31112788 — intervention group
Group type: EXPERIMENTAL
Intervention: Citalopram
Number of subjects: 24
Study 27543832 — intervention group
Group type: EXPERIMENTAL
Intervention: female‐specific group or individual outpatient treatment
Number of subjects: 138
Study 26417460 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Training Group
Number of subjects: 209
Study 26417460 — intervention group
Group type: COMPARATOR
Intervention: Active Control Group
Number of subjects: 209
Study 22945607 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral iron supplementation (50 mg, 4 times a week for 8.5 months)
Number of subjects: 321
Study 22945607 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral iron supplementation
Number of subjects: 321
Study 21367998 — intervention group
Group type: EXPERIMENTAL
Intervention: Rotation condition
Number of subjects: 15
Study 21367998 — intervention group
Group type: COMPARATOR
Intervention: No-rotation condition
Number of subjects: 15
Study 19150528 — intervention group
Group type: EXPERIMENTAL
Intervention: Shared medical appointment intervention led by an advanced practice nurse
Number of subjects: 0
Study 19150528 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 0
Study 18604013 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal Pethidine (1mg/kg)
Number of subjects: 60
Study 18604013 — intervention group
Group type: COMPARATOR
Intervention: Intrathecal Bupivacaine heavy (2.2ml of 0.5%)
Number of subjects: 60
Study 14712164 — intervention group
Group type: EXPERIMENTAL
Intervention: EM trial (exercise 30 minutes before the fat meal)
Number of subjects: 10
Study 14712164 — intervention group
Group type: EXPERIMENTAL
Intervention: ME trial (exercise 90 minutes after the fat meal)
Number of subjects: 10
Study 14712164 — intervention group
Group type: COMPARATOR
Intervention: CON trial (fat meal only)
Number of subjects: 10
Study 14712164 — intervention group
Group type: EXPERIMENTAL
Intervention: EM trial
Number of subjects: 10
Study 14712164 — intervention group
Group type: EXPERIMENTAL
Intervention: ME trial
Number of subjects: 10
Study 14712164 — intervention group
Group type: COMPARATOR
Intervention: CON trial
Number of subjects: 10
Study 11232677 — intervention group
Group type: COMPARATOR
Intervention: Nasogastric administration of SOS (40 mg dose)
Number of subjects: 9
Study 11232677 — intervention group
Group type: EXPERIMENTAL
Intervention: Jejunal/duodenal administration of SOS (40 mg dose)
Number of subjects: 9
Study 11232677 — intervention group
Group type: EXPERIMENTAL
Intervention: All routes of administration (nasogastric, jejunal, duodenal)
Number of subjects: 9
Study 9490600 — intervention group
Group type: EXPERIMENTAL
Intervention: Thyroxine suppressive therapy
Number of subjects: 0
Study 9490600 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative thyroxine therapy
Number of subjects: 0
Study 9490600 — intervention group
Group type: COMPARATOR
Intervention: Monitoring without thyroxine treatment
Number of subjects: 0
Study 7817355 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg trandolapril once daily for 30 days (D21 to D50)
Number of subjects: 23
Study 29625762 — intervention group
Group type: EXPERIMENTAL
Intervention: PCT and antidepressants
Number of subjects: 289
Study 29625762 — intervention group
Group type: COMPARATOR
Intervention: Antidepressants alone
Number of subjects: 289
Study 29625762 — intervention group
Group type: EXPERIMENTAL
Intervention: PCT with tapering of antidepressants
Number of subjects: 289
Study 26220763 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotics (Bifidobacterium lactis, Bifidobacterium longum, or a combination of both)
Number of subjects: 199